SparingVision logo

SparingVision

SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.

2

Funding Rounds

$97.5m

Money raised

Overview

SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.

Funding series

Funding Series Analysis

The company SparingVision has raised a total of $53m in funding over 2 rounds.

Key Insights:

  • SparingVision October 2020 Series A Funding Round: $53m
  • SparingVision Series A round October 2020: $44.5m
SparingVision logo
SparingVision October 2020 Series A Funding Round $53m
SparingVision logo
SparingVision Series A round October 2020 $44.5m